IGC Pharma, Inc.

IGC · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$1,105$454$405$470
Short-Term Investments$0$0$0$0
Receivables$41$185$77$49
Inventory$658$1,349$1,360$1,433
Other Curr. Assets$200$165$1,054$1,099
Total Curr. Assets$2,004$2,153$2,896$3,051
Property Plant & Equip (Net)$2,188$3,113$3,318$3,477
Goodwill$0$0$0$0
Intangibles$4,879$1,997$1,852$1,869
Long-Term Investments$0$680$680$679
Tax Assets$0$0$0$0
Other NC Assets$672$0$1$2
Total NC Assets$7,739$5,790$5,851$6,027
Other Assets$0$0$0$0
Total Assets$9,743$7,943$8,747$9,078
Liabilities
Payables$628$933$883$835
Short-Term Debt$0$62$94$251
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$886$730$1,280$1,571
Total Curr. Liab.$1,514$1,725$2,257$2,657
LT Debt$137$140$144$146
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$16$16
Total NC Liab.$137$140$160$162
Other Liabilities$0$0$0$0
Cap. Leases$0$69$104$136
Total Liabilities$1,651$1,865$2,417$2,819
Equity
Pref Stock$0$0$0$0
Common Stock$135,774$131,920$130,570$129,307
Retained Earnings-$122,828-$122,343-$120,744-$119,589
AOCI-$4,854-$3,499-$3,496-$3,459
Other Equity$0$0$0$0
Total Equity$8,092$6,078$6,330$6,259
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$9,743$7,943$8,747$9,078
Net Debt-$968-$252-$167-$73